İçeriğe geç
debya
Türkçe
Giriş yap Ücretsiz üye ol
Bluesky’da aç Bu hesabı takip et

Jeff Coller

@jmcoller.bsky.social did:plc:i74zljkbrbibk7txfptqqzd6

RNA Biologist - Bloomberg Distinguished Professor of mRNA Biology and Therapeutics. Director of the Hopkins RNA Innovation Center. Cofounder - Tevard Biosciences. Cofounder - Alliance for mRNA Medicines. Cofounder - Foundation for mRNA Medicines.

Bluesky’a katılma tarihi:

Takipçi
926
Takip edilen
653
Post
57
Sıralamaya girdiği gün
0

Özet

Jeff Coller (@jmcoller.bsky.social), 17 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 926 takipçisi var, 653 hesabı takip ediyor ve 57 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • JHU Bloomberg Distinguished Professorships@jhu-bdps.bsky.social

    Join BDP @jmcoller.bsky.social as he moderates a panel on the future of medical treatment at the Future of Next event on November 10, at the Johns Hopkins University Bloomberg Center in Washington, DC. Learn more: web.cvent.com/event/3619b5...

    Postu göster
  • JHU Bloomberg Distinguished Professorships@jhu-bdps.bsky.social

    In a @nytimes.com op-ed, BDP @jmcoller.bsky.social urges the US to develop and maintain a system that can fight back against AI-designed biological threats. www.nytimes.com/2026/10/12/o...

    Postu göster
  • The New York Times@nytimes.com

    In @nytopinion.nytimes.com We need to “enable the biosecurity community to develop countermeasures — vaccines, antibodies, antivirals and diagnostics — at a speed we haven’t seen since the Covid-19 pandemic,” Jeff Coller writes.

    Postu göster
  • Jamie Cate@jhdcate.bsky.social

    A note on the proposed rule, "Regulation For Federal Financial Assistance," www.regulations.gov/document/OMB... I posted comments on Weds 6/17, and they just appeared today. Keep them coming!

    Postu göster
  • The New York Times@nytimes.com

    In Opinion The system that turned Gila monster venom into GLP-1 drugs is being dismantled through research budget cuts, Jeff Coller writes in a guest essay. “Less support for scientists means strange questions no one will get to chase. Exploring those questions is how medicine advances.”

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.